BDBM160240 US9040663, 86

SMILES CC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H]1CCC(=O)NCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc(cc2)C#N)NC(=O)[C@H](CCC(N)=O)NC1=O)C(O)=O

InChI Key InChIKey=BFTHCBGAHXLIQX-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 160240   

TargetMelanocortin receptor 4(Human)
Astrazeneca

US Patent
LigandPNGBDBM160240(US9040663, 86)
Affinity DataKi:  40nM ΔG°:  -10.5kcal/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2015
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Astrazeneca

US Patent
LigandPNGBDBM160240(US9040663, 86)
Affinity DataKi:  3.97E+3nM ΔG°:  -7.66kcal/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2015
Entry Details
US Patent